439 related articles for article (PubMed ID: 27026420)
1. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
[TBL] [Abstract][Full Text] [Related]
3. Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
Becker J; Callegaro D; Lana-Peixoto MA; Talim N; Vidaletti T; de Paula Corrêa M; Gomes I
J Neurol Sci; 2016 Apr; 363():236-9. PubMed ID: 27000256
[TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
Soilu-Hänninen M; Airas L; Mononen I; Heikkilä A; Viljanen M; Hänninen A
Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
[TBL] [Abstract][Full Text] [Related]
5. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Smolders J; Menheere P; Kessels A; Damoiseaux J; Hupperts R
Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
[TBL] [Abstract][Full Text] [Related]
9. Seasonal variations of 25-OH vitamin D serum levels are associated with clinical disease activity in multiple sclerosis patients.
Hartl C; Obermeier V; Gerdes LA; Brügel M; von Kries R; Kümpfel T
J Neurol Sci; 2017 Apr; 375():160-164. PubMed ID: 28320120
[TBL] [Abstract][Full Text] [Related]
10. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.
Kragt J; van Amerongen B; Killestein J; Dijkstra C; Uitdehaag B; Polman Ch; Lips P
Mult Scler; 2009 Jan; 15(1):9-15. PubMed ID: 18701572
[TBL] [Abstract][Full Text] [Related]
11. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
Stein MS; Ward GJ; Butzkueven H; Kilpatrick TJ; Harrison LC
Mol Med; 2018 May; 24(1):27. PubMed ID: 30134801
[TBL] [Abstract][Full Text] [Related]
12. Bone metabolism and vitamin D status in patients with multiple sclerosis.
Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.
Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Kallaur AP; Mezzaroba L; Lozovoy MAB; Sabino BS; Ferreira KPZ; Pereira WLCJ; Kaimen-Maciel DR; Dichi I; Reiche EMV
J Neurol Sci; 2017 Oct; 381():213-219. PubMed ID: 28991684
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.
Bettencourt A; Boleixa D; Reguengo H; Samões R; Santos E; Oliveira JC; Silva B; Costa PP; da Silva AM
J Steroid Biochem Mol Biol; 2018 Jun; 180():137-141. PubMed ID: 28951256
[TBL] [Abstract][Full Text] [Related]
15. Concentration of 25(OH)D₃ and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.
Kubicka K; Pierzchała K
Neurol Neurochir Pol; 2013; 47(2):126-30. PubMed ID: 23650000
[TBL] [Abstract][Full Text] [Related]
16. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
Wang C; Zeng Z; Wang B; Guo S
J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420
[TBL] [Abstract][Full Text] [Related]
17. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
[TBL] [Abstract][Full Text] [Related]
18. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
Zhang Y; Liu G; Han X; Dong H; Geng J
J Neuroimmunol; 2016 Aug; 297():127-31. PubMed ID: 27397085
[TBL] [Abstract][Full Text] [Related]
19. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
Smolders J; Peelen E; Thewissen M; Menheere P; Damoiseaux J; Hupperts R
Mult Scler; 2014 Apr; 20(4):433-7. PubMed ID: 23959712
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
